MedPath

Analgesic Efficacy of Ultrasound Guided Serratus Anterior Plane Block and Pectoral Nerve Block II

Not Applicable
Recruiting
Conditions
Anesthesia
Radical Mastectomy
Registration Number
NCT06188156
Lead Sponsor
Azhar University
Brief Summary

Modified Radical Mastectomy accounts for 31% of all breast surgeries and considered the fundamental surgical management for breast cancer. Nearly 40-60% of patients experience severe acute postoperative pain. This pain might persist for 6-12 months and result in post-mastectomy pain syndrome and complex regional pain syndrome (causalgia)

Detailed Description

There are some local or regional nerve blocks in breast surgeries performed as core components of multimodal analgesia and enhanced recovery after surgery (ERAS), including thoracic epidural (TEB), interscalene brachial plexus, paravertebral, ultrasound-guided pectoral nerve block ( PECS II ), ultrasound-guided serratus anterior plane block (SAPB) and erector spinae plane block .

Thoracic epidural (TEB) is the gold standard technique following breast surgery, but there is still a problem with the adequacy of thoracic and axillary blockage during lymph node dissection .

Modified PECS's block" or PECS block type II aimed to block the axilla that is vital for axillary clearances and the intercostal nerves, necessary for wide excisions which can provide analgesia after breast surgery.

In the ultrasound-guided serratus anterior plane block (SAPB), the local anesthetic (LA) is injected in the compartment between the serratus anterior and latissimus dorsi muscles. SAPB anesthetizes the intercostobrachial nerve, lateral cutaneous branches of the intercostal nerves (T3-T9), long thoracic nerve, and thoracodorsal nerve thus providing analgesia for breast and lateral thoracic wall surgeries

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
99
Inclusion Criteria
  • Women aged 35-65 years.
  • BMI 18.5 - 25 kg/m2.
  • American Society of Anesthesiologists (ASA) I-II.
Exclusion Criteria
  • Patient refusal.
  • Coagulopathy.
  • Mental and psychiatric disorders.
  • History of chronic pain.
  • Hypersensitivity or contraindication to any of study drugs
  • Previous chemotherapy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Measurement of Post-operative PainFirst 24-hour analgesic after Mastectomy

Assessment of the pain post-operatively in patients with pain assessed by VAS score : Total scores vary from 0 to 10 in this method, with a higher score indicating more severe pain

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Al-Azhar University hospitals

🇪🇬

Cairo, Egypt

Al-Azhar University hospitals
🇪🇬Cairo, Egypt
Mohamed Abdelgawad, Assist.Prof
Contact
+201091945931
abosoad.mohamed2017@gmail.com
Mohamed Abdelgawad Aboelsuod, Assist.Prof.
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.